{"id":5987,"date":"2026-03-06T16:54:40","date_gmt":"2026-03-06T11:24:40","guid":{"rendered":"https:\/\/tradebrains.in\/money\/?p=5987"},"modified":"2026-03-06T17:14:18","modified_gmt":"2026-03-06T11:44:18","slug":"7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/","title":{"rendered":"7 Best Pharma Sector Mutual Funds Delivering Up to 28.4% CAGR in the Last 3 Years"},"content":{"rendered":"\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><strong>Synopsis: <\/strong><em>Pharma sector mutual funds invest in India\u2019s pharmaceutical and healthcare companies, offering long-term growth by capitalizing on rising domestic and global demand for medicines, diagnostics, and healthcare services. This guide ranks the top-performing funds of 2026 based on 3 and 5 year-returns, fund size, and expense ratio.<\/em><\/p>\n<\/blockquote>\n\n\n\n<p>India established itself as a worldwide pharmaceutical leader through its production of generic drugs and vaccines and its healthcare research activities. The growing global demand for the sector has created more interest in mutual funds that focus on specific industries. Pharma sector funds primarily invest in healthcare companies, which provide investors with better potential returns but higher investment risks than diversified equity funds. The process of selecting an appropriate fund needs performance metric assessment together with analysis of fund size and expense ratio data.<\/p><div class=\"trade-content-3\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1310246234\"><a data-no-instant=\"1\" href=\"https:\/\/tradebrains.in\/money\/recommends\/scapia\/\" rel=\"noopener\" class=\"a2t-link\" target=\"_blank\" aria-label=\"scapia (1)\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2025\/12\/scapia-1.jpg\" alt=\"scapia (1)\"  srcset=\"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2025\/12\/scapia-1.jpg 1000w, https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2025\/12\/scapia-1-980x980.jpg 980w, https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2025\/12\/scapia-1-480x480.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw\" width=\"350\" height=\"350\"  style=\"display: inline-block;\" \/><\/a><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-top-pharma-sector-mutual-funds-2026\" style=\"font-size:22px\"><strong>Top Pharma Sector Mutual Funds (2026)<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-1-sbi-healthcare-opportunities-fund-direct-plan-growth\" style=\"font-size:18px\"><strong>1. <a href=\"https:\/\/groww.in\/mutual-funds\/sbi-pharma-fund-direct-growth\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">SBI Healthcare Opportunities Fund Direct Plan &#8211; Growth<\/a><\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>NAV: \u20b9494.54<\/li>\n\n\n\n<li>AUM: \u20b93,822.73 Cr<\/li>\n\n\n\n<li>Expense Ratio: 0.91%<\/li>\n\n\n\n<li>Exit load: 0.50% if redeemed within 15 days<\/li>\n\n\n\n<li>Monthly SIP: \u20b9500<\/li>\n\n\n\n<li>One Time: \u20b95000<\/li>\n<\/ul>\n\n\n\n<p><strong>Performance snapshot:&nbsp;<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>3-Year CAGR: 27.3%<\/li>\n\n\n\n<li>5-Year CAGR: 18.4%<\/li>\n\n\n\n<li>3-Year Absolute Return: 107.4%<\/li>\n\n\n\n<li>5-Year Absolute Return: 130.5%<\/li>\n<\/ul>\n\n\n\n<p><strong>Category Comparison (5-Year):<\/strong><\/p><div class=\"trade-in-content\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1241666729\"><script data-cfasync=\"false\" type=\"text\/javascript\" id=\"AdsCoreLoader101144\" src=\"https:\/\/sads.adsboosters.xyz\/fbda060f29d5b8e8c653abce4ac69b7b.js\"><\/script>\r\n\u00a0<div class=\"ads-core-ads\"><\/div><\/div>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fund 5-Year CAGR: 18.4%<\/li>\n\n\n\n<li>Healthcare Category Average (5-Year): 14.6%&nbsp;<\/li>\n\n\n\n<li>Outperformance: +3.8 percentage points<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-2-nbsp-icici-prudential-pharma-healthcare-and-diagnostics-p-h-d-fund-direct-growth\" style=\"font-size:18px\"><strong>2.&nbsp;<a href=\"https:\/\/groww.in\/mutual-funds\/icici-prudential-pharma-healthcare-and-diagnostics-(p.h.d)-fund-direct-growth\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct &#8211; Growth<\/a><\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>NAV: \u20b941.23<\/li>\n\n\n\n<li>AUM: \u20b96,658.41 Cr<\/li>\n\n\n\n<li>Expense Ratio: 1.04%<\/li>\n\n\n\n<li>Exit load: 0.1% if redeemed within 15 days<\/li>\n\n\n\n<li>Monthly SIP: \u20b9100<\/li>\n\n\n\n<li>One Time: \u20b95000<\/li>\n<\/ul>\n\n\n\n<p><strong>Performance snapshot:&nbsp;<\/strong><\/p><div class=\"trade-content\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2734749278\"><div translate=\"no\" class='mailmunch-forms-widget-1169732'><\/div><\/div>\n\n\n\n<ul class=\"wp-block-list\">\n<li>3-Year CAGR: 28.4%<\/li>\n\n\n\n<li>5-Year CAGR: 18.0%<\/li>\n\n\n\n<li>3-Year Absolute Return: 113.7%<\/li>\n\n\n\n<li>5-Year Absolute Return: 129.2%<\/li>\n<\/ul>\n\n\n\n<p><strong>Category Comparison (5-Year)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fund 5-Year CAGR: 18.0%<\/li>\n\n\n\n<li>Healthcare Category Average (5-Year): 14.6%&nbsp;<\/li>\n\n\n\n<li>Outperformance: +3.4 percentage points<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-dsp-healthcare-fund-direct-growth\" style=\"font-size:18px\"><strong>3. <a href=\"https:\/\/groww.in\/mutual-funds\/dsp-healthcare-fund-direct-growth\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">DSP Healthcare Fund Direct &#8211; Growth<\/a><\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>NAV: \u20b941.62<\/li>\n\n\n\n<li>AUM: \u20b92,971.07 Cr<\/li>\n\n\n\n<li>Expense Ratio: 0.66%<\/li>\n\n\n\n<li>Exit load: 0.50% if redeemed within 1 month<\/li>\n\n\n\n<li>Monthly SIP: \u20b9100<\/li>\n\n\n\n<li>One Time: \u20b9100<\/li>\n<\/ul>\n\n\n\n<p><strong>Performance Snapshot<\/strong><\/p><div class=\"trade-content-2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3754073707\"><a data-no-instant=\"1\" href=\"https:\/\/tradebrains.in\/get\/voltmoney\/\" rel=\"noopener\" class=\"a2t-link\" aria-label=\"LAMF3 300_250 (1)\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2025\/11\/LAMF3-300_250-1.png\" alt=\"\"  width=\"300\" height=\"250\"   \/><\/a><\/div>\n\n\n\n<ul class=\"wp-block-list\">\n<li>3-Year CAGR: 22.9%<\/li>\n\n\n\n<li>5-Year CAGR: 16%<\/li>\n\n\n\n<li>3-Year Absolute Return: 80.8%<\/li>\n\n\n\n<li>5-Year Absolute Return: 105.2%<\/li>\n<\/ul>\n\n\n\n<p><strong>Category Comparison (5-Year)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fund 5-Year CAGR: 16%<\/li>\n\n\n\n<li>Healthcare Category Average (5-Year): 14.6%<\/li>\n\n\n\n<li>Outperformance: +1.4 percentage points<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-4-nbsp-tata-india-pharma-amp-healthcare-fund-direct-growth\" style=\"font-size:18px\"><strong>4. <a href=\"https:\/\/groww.in\/mutual-funds\/tata-india-pharma-and-healthcare-fund-direct-growth\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">&nbsp;Tata India Pharma &amp; Healthcare Fund Direct &#8211; Growth<\/a><\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>NAV: \u20b934.96<\/li>\n\n\n\n<li>AUM: \u20b91,239.57 Cr<\/li>\n\n\n\n<li>Expense Ratio: 0.69%<\/li>\n\n\n\n<li>Exit load: 0.25% if redeemed within 30 days<\/li>\n\n\n\n<li>Monthly SIP: \u20b9100<\/li>\n\n\n\n<li>One Time: \u20b95000<\/li>\n<\/ul>\n\n\n\n<p><strong>Performance Snapshot:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>3-Year CAGR: 25.6%<\/li>\n\n\n\n<li>5-Year CAGR: 17.1%<\/li>\n\n\n\n<li>3-Year Absolute Return: 99.6%<\/li>\n\n\n\n<li>5-Year Absolute Return: 119.3%<\/li>\n<\/ul>\n\n\n\n<p><strong>Category Comparison (5-Year)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fund 5-Year CAGR: 17.1%<\/li>\n\n\n\n<li>Healthcare Category Average (5-Year): 14.6%<\/li>\n\n\n\n<li>Outperformance: +2.5 percentage point<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-5-nippon-india-pharma-fund-direct-growth\" style=\"font-size:18px\"><strong>5. <a href=\"https:\/\/groww.in\/mutual-funds\/nippon-india-pharma-fund-direct-growth\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Nippon India Pharma Fund Direct &#8211; Growth<\/a><\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>NAV: \u20b9573.48<\/li>\n\n\n\n<li>AUM: \u20b97,875.40 Cr<\/li>\n\n\n\n<li>Expense Ratio: 0.91%<\/li>\n\n\n\n<li>Exit load: 1% if redeemed within 1 month<\/li>\n\n\n\n<li>Monthly SIP: \u20b9100<\/li>\n\n\n\n<li>One Time: \u20b95000<\/li>\n<\/ul>\n\n\n\n<p><strong>Performance Snapshot<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>3-Year CAGR: 25.1%<\/li>\n\n\n\n<li>5-Year CAGR: 16.7%<\/li>\n\n\n\n<li>3-Year Absolute Return: 96.5%<\/li>\n\n\n\n<li>5-Year Absolute Return: 115.8%<\/li>\n<\/ul>\n\n\n\n<p><strong>Category Comparison (5-Year)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fund 5-Year CAGR: 16.7%<\/li>\n\n\n\n<li>Healthcare Category Average (5-Year): 14.6%<\/li>\n\n\n\n<li>Outperformance: +2.1 percentage points<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-6-aditya-birla-sun-life-pharma-amp-healthcare-fund-direct-growth\" style=\"font-size:18px\">6. <a href=\"https:\/\/groww.in\/mutual-funds\/aditya-birla-sun-life-pharma-healthcare-fund-direct-growth\" target=\"_blank\" rel=\"noreferrer noopener nofollow\"><strong>Aditya Birla Sun Life Pharma &amp; Healthcare Fund Direct &#8211; Growth<\/strong><\/a><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>NAV: \u20b934.45<\/li>\n\n\n\n<li>AUM: \u20b9812.03 Cr<\/li>\n\n\n\n<li>Expense Ratio: 1.02%<\/li>\n\n\n\n<li>Exit load: 1% if redeemed within 30 days<\/li>\n\n\n\n<li>Monthly SIP: \u20b9100<\/li>\n\n\n\n<li>One Time: \u20b91000<\/li>\n<\/ul>\n\n\n\n<p><strong>Performance Snapshot<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>3-Year CAGR: 25.7%<\/li>\n\n\n\n<li>5-Year CAGR: 16%<\/li>\n\n\n\n<li>3-Year Absolute Return: 99.1%<\/li>\n\n\n\n<li>5-Year Absolute Return: 108%<\/li>\n<\/ul>\n\n\n\n<p><strong>Category Comparison (5-Year)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fund 5-Year CAGR: 16%<\/li>\n\n\n\n<li>Healthcare Category Average (5-Year): 14.6%<\/li>\n\n\n\n<li>Outperformance: +1.4 percentage point<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-7-mirae-asset-healthcare-fund-direct-growth\" style=\"font-size:18px\"><strong>7. <a href=\"https:\/\/groww.in\/mutual-funds\/mirae-asset-healthcare-fund-direct-growth\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Mirae Asset Healthcare Fund Direct &#8211; Growth<\/a><\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>NAV: \u20b944.01<\/li>\n\n\n\n<li>AUM: \u20b92,639.92 Cr<\/li>\n\n\n\n<li>Expense Ratio: 0.48%<\/li>\n\n\n\n<li>Exit load: 1% if redeemed within 1 year<\/li>\n\n\n\n<li>Monthly SIP: \u20b999<\/li>\n\n\n\n<li>One Time: \u20b95000<\/li>\n<\/ul>\n\n\n\n<p><strong>Performance Snapshot<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>3-Year CAGR: 26.9%<\/li>\n\n\n\n<li>5-Year CAGR: 17.8%<\/li>\n\n\n\n<li>3-Year Absolute Return: 104.7%<\/li>\n\n\n\n<li>5-Year Absolute Return: 125.7%<\/li>\n<\/ul>\n\n\n\n<p><strong>Category Comparison (5-Year)<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fund 5-Year CAGR: 17.8%<\/li>\n\n\n\n<li>Healthcare Category Average (5-Year): 14.6%<\/li>\n\n\n\n<li>Outperformance: +3.2 percentage point<\/li>\n<\/ul>\n\n\n\n<p><strong><em>Note:<\/em><\/strong><em> The NAV, AUM, expense ratio, and the ratios mentioned for the funds are sourced from <strong>Groww<\/strong> as of <\/em><strong><em>6th March 2026.<\/em><\/strong><\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><strong>Also read:<\/strong> <a href=\"https:\/\/tradebrains.in\/money\/best-4-mutual-funds-for-investors-in-their-30s-top-performer-delivered-18-86-cagr-in-past-5-years\/\" target=\"_blank\" rel=\"noreferrer noopener\">Best 4 Mutual Funds for Investors in Their 30s &#8211; Top Performer Delivered 18.86% CAGR in Past 5 Years<\/a><\/p>\n<\/blockquote>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\">Fund Name<\/td><td class=\"has-text-align-center\" data-align=\"center\">NAV<\/td><td class=\"has-text-align-center\" data-align=\"center\">AUM (\u20b9 Cr)<\/td><td class=\"has-text-align-center\" data-align=\"center\">3Y CAGR<\/td><td class=\"has-text-align-center\" data-align=\"center\">5Y CAGR<\/td><td class=\"has-text-align-center\" data-align=\"center\">Outperformance (vs Category)<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">SBI Healthcare Opportunities Fund<\/td><td class=\"has-text-align-center\" data-align=\"center\">\u20b9494.54<\/td><td class=\"has-text-align-center\" data-align=\"center\">3,822.73<\/td><td class=\"has-text-align-center\" data-align=\"center\">27.3%<\/td><td class=\"has-text-align-center\" data-align=\"center\">18.4%<\/td><td class=\"has-text-align-center\" data-align=\"center\">+3.8 pp<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">ICICI Prudential Pharma Healthcare &amp; Diagnostics Fund<\/td><td class=\"has-text-align-center\" data-align=\"center\">\u20b941.23<\/td><td class=\"has-text-align-center\" data-align=\"center\">6,658.41<\/td><td class=\"has-text-align-center\" data-align=\"center\">28.4%<\/td><td class=\"has-text-align-center\" data-align=\"center\">18.0%<\/td><td class=\"has-text-align-center\" data-align=\"center\">+3.4 pp<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">DSP Healthcare Fund<\/td><td class=\"has-text-align-center\" data-align=\"center\">\u20b941.62<\/td><td class=\"has-text-align-center\" data-align=\"center\">2,971.07<\/td><td class=\"has-text-align-center\" data-align=\"center\">22.9%<\/td><td class=\"has-text-align-center\" data-align=\"center\">16.0%<\/td><td class=\"has-text-align-center\" data-align=\"center\">+1.4 pp<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Tata India Pharma &amp; Healthcare Fund<\/td><td class=\"has-text-align-center\" data-align=\"center\">\u20b934.96<\/td><td class=\"has-text-align-center\" data-align=\"center\">1,239.57<\/td><td class=\"has-text-align-center\" data-align=\"center\">25.6%<\/td><td class=\"has-text-align-center\" data-align=\"center\">17.1%<\/td><td class=\"has-text-align-center\" data-align=\"center\">+2.5 pp<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Nippon India Pharma Fund<\/td><td class=\"has-text-align-center\" data-align=\"center\">\u20b9573.48<\/td><td class=\"has-text-align-center\" data-align=\"center\">7,875.40<\/td><td class=\"has-text-align-center\" data-align=\"center\">25.1%<\/td><td class=\"has-text-align-center\" data-align=\"center\">16.7%<\/td><td class=\"has-text-align-center\" data-align=\"center\">+2.1 pp<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Aditya Birla Sun Life Pharma &amp; Healthcare Fund<\/td><td class=\"has-text-align-center\" data-align=\"center\">\u20b934.45<\/td><td class=\"has-text-align-center\" data-align=\"center\">812.03<\/td><td class=\"has-text-align-center\" data-align=\"center\">25.7%<\/td><td class=\"has-text-align-center\" data-align=\"center\">16.0%<\/td><td class=\"has-text-align-center\" data-align=\"center\">+1.4 pp<\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">Mirae Asset Healthcare Fund<\/td><td class=\"has-text-align-center\" data-align=\"center\">\u20b944.01<\/td><td class=\"has-text-align-center\" data-align=\"center\">2,639.92<\/td><td class=\"has-text-align-center\" data-align=\"center\">26.9%<\/td><td class=\"has-text-align-center\" data-align=\"center\">17.8%<\/td><td class=\"has-text-align-center\" data-align=\"center\">+3.2 pp<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-who-should-consider-these-funds\" style=\"font-size:22px\"><strong>Who Should Consider These Funds<\/strong><\/h2>\n\n\n\n<p>Pharma sector mutual funds serve as a suitable investment option for investors who want to achieve long-term growth over 5 to 7 years while investing in India&#8217;s healthcare and pharmaceutical sector. The investment strategy does not suit investors who prefer stable returns with minimal risk.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-conclusion\" style=\"font-size:22px\"><strong>Conclusion<\/strong><\/h2>\n\n\n\n<p>Pharma sector mutual funds show strong long-term growth potential through their investment in India&#8217;s healthcare and pharmaceutical markets. The top funds, SBI Healthcare Opportunities, ICICI Prudential PHD, and Mirae Asset Healthcare, have consistently delivered better performance than their respective category averages. The combination of these funds with diversified equity investments provides a solution to manage risk while achieving maximum investment returns.<\/p>\n\n\n\n<p><strong><em>Disclaimer: <\/em><\/strong><em>The information provided in this article is for educational purposes only and should not be construed as financial advice or investment recommendation. Returns mentioned are based on historical performance and may not be sustained in the future. Mutual fund investments are subject to market risks, including potential loss of capital. Investors are advised to assess their risk appetite and financial goals and to consult a certified financial advisor before investing.<\/em><\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>Written by Ameet S<\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>Synopsis: Pharma sector mutual funds invest in India\u2019s pharmaceutical and healthcare companies, offering long-term growth by capitalizing on rising domestic and global demand for medicines, diagnostics, and healthcare services. This guide ranks the top-performing funds of 2026 based on 3 and 5 year-returns, fund size, and expense ratio. India established itself as a worldwide pharmaceutical [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":6015,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[7,14],"tags":[2101,2051,318,2100,2099,2098],"ppma_author":[1013],"class_list":["post-5987","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mutual-funds","category-trending","tag-healthcare-mutual-funds","tag-high-cagr-mutual-funds","tag-mutual-funds","tag-pharma-mutual-funds","tag-pharma-sector-delivering-high-returns","tag-pharma-sector-mutual-funds"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.3 (Yoast SEO v26.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>7 Best Pharma Sector Mutual Funds Delivering Up to 28.4% CAGR in the Last 3 Years<\/title>\n<meta name=\"description\" content=\"Pharma sector mutual funds invest in India\u2019s pharmaceutical and healthcare companies, offering long-term growth by capitalizing on rising domestic and global demand for medicines, diagnostics, and healthcare services. This guide ranks the top-performing funds of 2026 based on 3 and 5 year-returns, fund size, and expense ratio.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"7 Best Pharma Sector Mutual Funds Delivering Up to 28.4% CAGR in the Last 3 Years\" \/>\n<meta property=\"og:description\" content=\"Pharma sector mutual funds invest in India\u2019s pharmaceutical and healthcare companies, offering long-term growth by capitalizing on rising domestic and global demand for medicines, diagnostics, and healthcare services. This guide ranks the top-performing funds of 2026 based on 3 and 5 year-returns, fund size, and expense ratio.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Money\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-06T11:24:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-06T11:44:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2026\/03\/healthcare-mutual-funds.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"7 Best Pharma Sector Mutual Funds Delivering Up to 28.4% CAGR in the Last 3 Years\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/\",\"url\":\"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/\",\"name\":\"7 Best Pharma Sector Mutual Funds Delivering Up to 28.4% CAGR in the Last 3 Years\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/money\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2026\/03\/healthcare-mutual-funds.jpg\",\"datePublished\":\"2026-03-06T11:24:40+00:00\",\"dateModified\":\"2026-03-06T11:44:18+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/money\/#\/schema\/person\/b2727abbc1b037c476a03d78c5f7d1cd\"},\"description\":\"Pharma sector mutual funds invest in India\u2019s pharmaceutical and healthcare companies, offering long-term growth by capitalizing on rising domestic and global demand for medicines, diagnostics, and healthcare services. This guide ranks the top-performing funds of 2026 based on 3 and 5 year-returns, fund size, and expense ratio.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/#primaryimage\",\"url\":\"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2026\/03\/healthcare-mutual-funds.jpg\",\"contentUrl\":\"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2026\/03\/healthcare-mutual-funds.jpg\",\"width\":1280,\"height\":854,\"caption\":\"pharma sector mutual funds\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/money\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"7 Best Pharma Sector Mutual Funds Delivering Up to 28.4% CAGR in the Last 3 Years\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/money\/#website\",\"url\":\"https:\/\/tradebrains.in\/money\/\",\"name\":\"Trade Brains Money\",\"description\":\"Get the latest news on mutual funds, real estate and many more\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/money\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/money\/#\/schema\/person\/b2727abbc1b037c476a03d78c5f7d1cd\",\"name\":\"Trade Brains\",\"description\":\"Trade Brains Money\u2019s editorial team is a dedicated group of researchers, finance writers, and editors with over 10 years of experience, committed to delivering clear, accurate, and actionable insights across banking, credit cards, loans, real estate, personal finance, and taxation to help you make informed financial decisions.\",\"url\":\"https:\/\/tradebrains.in\/money\/author\/tb-money-editorial\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"7 Best Pharma Sector Mutual Funds Delivering Up to 28.4% CAGR in the Last 3 Years","description":"Pharma sector mutual funds invest in India\u2019s pharmaceutical and healthcare companies, offering long-term growth by capitalizing on rising domestic and global demand for medicines, diagnostics, and healthcare services. This guide ranks the top-performing funds of 2026 based on 3 and 5 year-returns, fund size, and expense ratio.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/","og_locale":"en_US","og_type":"article","og_title":"7 Best Pharma Sector Mutual Funds Delivering Up to 28.4% CAGR in the Last 3 Years","og_description":"Pharma sector mutual funds invest in India\u2019s pharmaceutical and healthcare companies, offering long-term growth by capitalizing on rising domestic and global demand for medicines, diagnostics, and healthcare services. This guide ranks the top-performing funds of 2026 based on 3 and 5 year-returns, fund size, and expense ratio.","og_url":"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/","og_site_name":"Trade Brains Money","article_published_time":"2026-03-06T11:24:40+00:00","article_modified_time":"2026-03-06T11:44:18+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2026\/03\/healthcare-mutual-funds.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_title":"7 Best Pharma Sector Mutual Funds Delivering Up to 28.4% CAGR in the Last 3 Years","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/","url":"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/","name":"7 Best Pharma Sector Mutual Funds Delivering Up to 28.4% CAGR in the Last 3 Years","isPartOf":{"@id":"https:\/\/tradebrains.in\/money\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2026\/03\/healthcare-mutual-funds.jpg","datePublished":"2026-03-06T11:24:40+00:00","dateModified":"2026-03-06T11:44:18+00:00","author":{"@id":"https:\/\/tradebrains.in\/money\/#\/schema\/person\/b2727abbc1b037c476a03d78c5f7d1cd"},"description":"Pharma sector mutual funds invest in India\u2019s pharmaceutical and healthcare companies, offering long-term growth by capitalizing on rising domestic and global demand for medicines, diagnostics, and healthcare services. This guide ranks the top-performing funds of 2026 based on 3 and 5 year-returns, fund size, and expense ratio.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/#primaryimage","url":"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2026\/03\/healthcare-mutual-funds.jpg","contentUrl":"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2026\/03\/healthcare-mutual-funds.jpg","width":1280,"height":854,"caption":"pharma sector mutual funds"},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/money\/7-best-pharma-sector-mutual-funds-delivering-up-to-28-4-cagr-in-the-last-3-years\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/money\/"},{"@type":"ListItem","position":2,"name":"7 Best Pharma Sector Mutual Funds Delivering Up to 28.4% CAGR in the Last 3 Years"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/money\/#website","url":"https:\/\/tradebrains.in\/money\/","name":"Trade Brains Money","description":"Get the latest news on mutual funds, real estate and many more","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/money\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/money\/#\/schema\/person\/b2727abbc1b037c476a03d78c5f7d1cd","name":"Trade Brains","description":"Trade Brains Money\u2019s editorial team is a dedicated group of researchers, finance writers, and editors with over 10 years of experience, committed to delivering clear, accurate, and actionable insights across banking, credit cards, loans, real estate, personal finance, and taxation to help you make informed financial decisions.","url":"https:\/\/tradebrains.in\/money\/author\/tb-money-editorial\/"}]}},"authors":[{"term_id":1013,"user_id":5,"is_guest":0,"slug":"tb-money-editorial","display_name":"Trade Brains","avatar_url":{"url":"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2025\/12\/trade-brains-logo.png","url2x":"https:\/\/tradebrains-wp.s3.ap-south-1.amazonaws.com\/money\/wp-content\/uploads\/2025\/12\/trade-brains-logo.png"},"author_category":"1","first_name":"Trade","last_name":"Brains","user_url":"","job_title":"","description":"Trade Brains Money\u2019s editorial team is a dedicated group of researchers, finance writers, and editors with over 10 years of experience, committed to delivering clear, accurate, and actionable insights across banking, credit cards, loans, real estate, personal finance, and taxation to help you make informed financial decisions."}],"_links":{"self":[{"href":"https:\/\/tradebrains.in\/money\/wp-json\/wp\/v2\/posts\/5987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/money\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/money\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/money\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/money\/wp-json\/wp\/v2\/comments?post=5987"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/money\/wp-json\/wp\/v2\/posts\/5987\/revisions"}],"predecessor-version":[{"id":6034,"href":"https:\/\/tradebrains.in\/money\/wp-json\/wp\/v2\/posts\/5987\/revisions\/6034"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/money\/wp-json\/wp\/v2\/media\/6015"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/money\/wp-json\/wp\/v2\/media?parent=5987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/money\/wp-json\/wp\/v2\/categories?post=5987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/money\/wp-json\/wp\/v2\/tags?post=5987"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/tradebrains.in\/money\/wp-json\/wp\/v2\/ppma_author?post=5987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}